---
figid: PMC2721971__tra0010-0982-f3
figlink: /pmc/articles/PMC2721971/figure/fig03/
number: Figure 3
caption: Besides well-known EGFR signaling pathways that link to the cell invasion
  and migration via activation of Ser/Thr kinases, EGFR can evoke a novel pathway
  that leads to the cancer invasion and metastasis, in which phosphorylated Tyr1068
  or Tyr1086 binds directly to the PH domain of GEP100. Through this binding, GEP100
  activates Arf6 and its downstream signaling pathway employing AMAP1 as its effector.
  For functioning of this pathway, it is prerequisite that both Arf6 and AMAP1 are
  highly overexpressed, and that Tyr1068 or Tyr1086 is highly phosphorylated. This
  EGFR-GEP100-Arf6-AMAP1 pathway plays pivotal roles not only in the formation and
  function of invadopodia, but also in perturbation of the E-cadherin-based cell–cell
  adhesion. Arf6 can be ubiquitinated by Fbx8, a component of the SCF complex. Loss
  of Fbx8 expression is frequently observed in different breast cancer cells, and
  contributes to their invasiveness. Monoubiquitination of AMAP1 by Cbl, via AMAP1's
  binding to CIN85, is also necessary for the invasion.
pmcid: PMC2721971
papertitle: The EGFR-GEP100-Arf6-AMAP1 Signaling Pathway Specific to Breast Cancer
  Invasion and Metastasis†.
reftext: Hisataka Sabe, et al. Traffic. 2009 Aug;10(8):982-993.
pmc_ranked_result_index: '1859'
pathway_score: 0.9658947
filename: tra0010-0982-f3.jpg
figtitle: EGFR-GEP100-Arf6-AMAP1 Signaling Pathway Specific to Breast Cancer Invasion
  and Metastasis†
year: '2009'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2721971__tra0010-0982-f3.html
  '@type': Dataset
  description: Besides well-known EGFR signaling pathways that link to the cell invasion
    and migration via activation of Ser/Thr kinases, EGFR can evoke a novel pathway
    that leads to the cancer invasion and metastasis, in which phosphorylated Tyr1068
    or Tyr1086 binds directly to the PH domain of GEP100. Through this binding, GEP100
    activates Arf6 and its downstream signaling pathway employing AMAP1 as its effector.
    For functioning of this pathway, it is prerequisite that both Arf6 and AMAP1 are
    highly overexpressed, and that Tyr1068 or Tyr1086 is highly phosphorylated. This
    EGFR-GEP100-Arf6-AMAP1 pathway plays pivotal roles not only in the formation and
    function of invadopodia, but also in perturbation of the E-cadherin-based cell–cell
    adhesion. Arf6 can be ubiquitinated by Fbx8, a component of the SCF complex. Loss
    of Fbx8 expression is frequently observed in different breast cancer cells, and
    contributes to their invasiveness. Monoubiquitination of AMAP1 by Cbl, via AMAP1's
    binding to CIN85, is also necessary for the invasion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK8
  - HRAS
  - MAPK1
  - MAPK3
  - AKT1
  - MAPK11
  - BRAF
  - AKT3
  - MAP2K5
  - PIK3R3
  - GRB2
  - MAPK14
  - KRAS
  - NRAS
  - SOS1
  - RAF1
  - ARF6
  - CBL
  - GAB1
  - IQSEC1
  - FBXO8
  - PIK3CD
  - PIK3CG
  - ARAF
  - AKT2
  - MYCBPAP
  - MAP2K6
  - PIK3R6
  - EGF
  - EGFR
  - MAPK10
  - SH3KBP1
  - MAP2K7
  - MAP2K4
  - MAPK9
  - SOS2
  - MAPK13
  - MAPK12
  - MAP2K3
  - PIK3R5
  - PIK3R4
  - PDK1
  - PIK3CA
  - PIK3CB
  - Cancer
  - Lung cancer
  - Noonan syndrome
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K5
  entrez: '5607'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Arf6
  symbol: ARF6
  source: hgnc_symbol
  hgnc_symbol: ARF6
  entrez: '382'
- word: Cbl
  symbol: CBL
  source: hgnc_symbol
  hgnc_symbol: CBL
  entrez: '867'
- word: Gab1
  symbol: GAB1
  source: hgnc_symbol
  hgnc_symbol: GAB1
  entrez: '2549'
- word: GEP100
  symbol: GEP100
  source: hgnc_alias_symbol
  hgnc_symbol: IQSEC1
  entrez: '9922'
- word: Fbx8
  symbol: FBX8
  source: hgnc_alias_symbol
  hgnc_symbol: FBXO8
  entrez: '26269'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AMAP1
  symbol: AMAP-1
  source: hgnc_alias_symbol
  hgnc_symbol: MYCBPAP
  entrez: '84073'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: CIN85
  symbol: CIN85
  source: hgnc_alias_symbol
  hgnc_symbol: SH3KBP1
  entrez: '30011'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPKK
  symbol: MAPKK
  source: bioentities_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
